Carl Lindgren
Fortune : 127 987 $ au 31/07/2026
Fortune : 127 987 $ au 31/07/2026
Carl Lindgren is the founder of Manico AB, founded in 2012.
Current jobs include Chairman at Iconovo AB starting in 2024 and Director at Biomedica AB. Former jobs include Vice President-Depression Portfolio at H.
Lundbeck A, Vice President-Business Development at Karo Healthcare AB from 2017 to 2023, and Chief Business Development Officer at EQL Pharma AB from 2023 to 2026.
Education includes undergraduate studies at the University of Lund.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
EQL PHARMA AB 0,2 % | 31/03/2025 | 60 000 ( 0,2 % ) | 127 987 $ | 31/07/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| ICONOVO AB | Président | 01/01/2024 |
| Sociétés | Poste | Fin |
|---|---|---|
| EQL PHARMA AB | Corporate Officer/Principal | 30/06/2026 |
| KARO PHARMA AB (PUBL) | Corporate Officer/Principal | 01/04/2023 |
| H. LUNDBECK A/S | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 5 |
|---|---|
H. Lundbeck A/S
H. Lundbeck A/S Pharmaceuticals: MajorHealth Technology Engages in the research, development, production and sale of pharmaceuticals for the treatment of brain diseases | Health Technology |
Karo Healthcare AB
Karo Healthcare AB Household/Personal CareConsumer Non-Durables Manufactures skincare products, cosmetics, supplements and digestive pharmaceuticals | Consumer Non-Durables |
University of Lund
University of Lund Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
EQL Pharma AB
EQL Pharma AB Pharmaceuticals: GenericHealth Technology Manufactures and distributes generic and specialty pharmaceutical products | Health Technology |
Iconovo AB
Iconovo AB Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that manufactures and wholesales powder-based inhalation drugs and devices | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national